Philip Astley-Sparke

2021

In 2021, Philip Astley-Sparke earned a total compensation of $2.5M as Chief Executive Officer at Replimune Group, a 14% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$226,525
Option Awards$1,698,067
Salary$533,000
Total$2,457,592

Astley-Sparke received $1.7M in option awards, accounting for 69% of the total pay in 2021.

Astley-Sparke also received $226.5K in non-equity incentive plan and $533K in salary.

Rankings

In 2021, Philip Astley-Sparke's compensation ranked 5,219th out of 12,405 executives tracked by ExecPay. In other words, Astley-Sparke earned more than 57.9% of executives.

ClassificationRankingPercentile
All
5,219
out of 12,405
58th
Division
Manufacturing
2,191
out of 5,494
60th
Major group
Chemicals And Allied Products
949
out of 2,369
60th
Industry group
Drugs
848
out of 2,090
59th
Industry
Biological Products, Except Diagnostic Substances
208
out of 452
54th
Source: SEC filing on July 27, 2022.

Astley-Sparke's colleagues

We found one more compensation record of an executive who worked with Philip Astley-Sparke at Replimune Group in 2021.

2021

Robert Coffin

Replimune Group

President and Chief Research & Development Officer

News

In-depth

You may also like